InSightec Report issue

For profit Phase 2
Founded: Tirat Carmel Israel (1999)

Organization Overview

First Clinical Trial
2020
NCT04417088
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

InSightec